跳至主要内容
临床试验/CTRI/2023/05/052619
CTRI/2023/05/052619尚未招募Unknown

To study the utility of COX2 as immunohistochemical prognostic marker in comparison to various histopathological parameters and TNM staging in colorectal carcinoma

Datta Meghe institute of Medical Science0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.All cases diagnosed as colorectal carcinoma on histopathology.
  • 2.All colectomy/Hemicolectomy/ Proctocolectomy resection specimens.
  • 3.Primary cases of colorectal carcinoma without any history of previous treatment.
  • 4.All patients presenting with colorectal carcinoma arising Denovo.

排除标准

  • 1.All inflammatory lesions, and other malignancies of the gastrointestinal tract.
  • 2.All biopsy specimens.
  • 3.All treated cases of colorectal carcinoma and cases with recurrence

研究者

发起方
Datta Meghe institute of Medical Science

相似试验